PackTalk is a blog for the Healthcare Packaging Industry

Eli Lilly Starts Human Study of Potential COVID-19 Antibody Test


Published on June 4, 2020

Companies and research institutions around the world are racing to find a viable treatment for COVID-19, which has already caused ~370,000 deaths worldwide and continues to rise. Eli Lilly recently announced their progress, and are moving into the human study portion of their antibody treatment. They have developed this treatment from a blood sample that was taken from one of the first patients in the United States to have recovered from the lung illness caused by COVID-19. 

Eli Lilly is anticipating results to their study by end of June. Read more about the treatment here.


Comments (0)

Related Articles

What Does a Packaging Engineer Do?

May 27, 2023

It's often said that "everything you see comes in a package." But have you ever stopped to think about what goes into creating that package? Or even WHO? Behind every great package is a packaging engineer—a niche profession. Those who are familiar with what a...

Learn More

An All Access Student Pass to the[PACK]out

May 27, 2023

Last week, I had the opportunity to attend the[PACK]out with the support and sponsorship of Oliver Healthcare Packaging. the[PACK]out is a healthcare packaging conference focused on providing industry professionals the opportunity to connect, collaborate, and...

Learn More

Investing in Europe

May 27, 2023

The Covid-19 pandemic exposed severe weaknesses in the global supply chain for medical device packaging. As a result, Oliver is committed to investing in regionalizing our supply chain. Recently, Oliver CEO, Mike Benevento, sat down with Medical Device...

Learn More

Stay Informed

To stay up to date on innovative technology and products, as well as industry trends, subscribe to Oliver’s PackTalk blog below.